Tiziana Life Sciences PLC Accustem Update
March 30 2021 - 7:30AM
RNS Non-Regulatory
TIDMTILS
Tiziana Life Sciences PLC
30 March 2021
Tiziana Life Sciences plc
("Tiziana" or the "Company")
Accustem Update
NEW YORK and LONDON - 30 March 2021 - Tiziana Life Sciences.
(NASDAQ: TLSA; LSE: TILS), a biotechnology company focused on
innovative therapeutics for oncology, inflammation, and infectious
diseases, is pleased to confirm that, in order to finalise the
distribution of shares in Accustem Sciences Limited ("Accustem") to
the holders of Tiziana shares in the US via its ADS program, it has
recently filed a Form 20-F with the Securities Exchange Commission
in the USA (the "SEC"). The Form 20-F (which gives full information
about the business of Accustem), can be found at
https://sec.report/CIK/0001850767.
Once the SEC has approved the Form 20-F (or it becomes
effective), the final aspect of the distribution will be complete
and Accustem will be an entirely separate entity and will move
forward with plans to secure its own listing.
In the meantime, Tiziana shareholders are directed to the
Accustem website at http://www.accustem.com/, where all further
developments and news will be published.
For further enquiries:
United Kingdom Investors:
Tiziana Life Sciences plc (TLSA)
Gabriele Cerrone, Chairman and founder +44 (0)20 7495 2379
U.S. Investor Relations Contact:
RedChip Companies, Inc.
Dave Gentry
407-491-4498
dave@redchip.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFBLFXFXLLBBQ
(END) Dow Jones Newswires
March 30, 2021 07:30 ET (11:30 GMT)
Tiziana Life Sciences (LSE:TILS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Tiziana Life Sciences (LSE:TILS)
Historical Stock Chart
From Oct 2023 to Oct 2024